CELLCEPT 200 MG/ML ORAL SUSP
FDA nonproprietary name: mycophenolate mofetil
For 225 mL
Pharmacies pay
$1,870.74 filed
225 × $8.31442 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: The Part B crosswalk’s package unit for J7529 could not be matched to the NADAC unit (ML), so the payment limit cannot be converted to a price per ML.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$2,156.35 estimated
$1,870.74 + $280.61 (15%) + $5.00 fee per fill = $2,156.35
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CELLCEPT 200 MG/ML ORAL SUSP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as mycophenolate mofetil, under the trade name “CellCept”.
FDA gives its dosage form as powder, for suspension and its route as oral.
The labeler, the company named on the label, is Genentech, Inc.
FDA’s Established Pharmacologic Class for it is Antimetabolite Immunosuppressant.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00004-0261-29.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1,870.74 for 225 mL (225 × $8.31442 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.98162 per ML filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes
The NDC
- 00004-0261-29 · Genentech, Inc. · $8.31442 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name mycophenolate mofetil with CELLCEPT 200 MG/ML ORAL SUSP.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CELLCEPT 200 MG/ML ORAL SUSP this page | $8.31442 per ML filed | We don’t know yet |
| CELLCEPT 250 MG CAPSULE | $8.64903 per EA filed | $0.10 per EA derived |
| CELLCEPT 500 MG TABLET | $17.33941 per EA filed | $0.20 per EA derived |
| MYCOPHENOLATE 200 MG/ML SUSP | $0.98162 per ML filed | We don’t know yet |
| MYCOPHENOLATE 250 MG CAPSULE | $0.13821 per EA filed | $0.10 per EA derived |
| MYCOPHENOLATE 500 MG TABLET | $0.26327 per EA filed | $0.20 per EA derived |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 225 mL? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: MYCOPHENOLATE 200 MG/ML SUSP. Ask your pharmacist or prescriber; do not switch on your own.
- How much is in the package I am getting? This page uses 225 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 225 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 225 mL in one package for this product’s NDC (“1 BOTTLE, PLASTIC in 1 CARTON (0004-0261-29) / 225 mL in 1 BOTTLE, PLASTIC”), so the card starts at one package: 225 ML. Change it to match your prescription.